NM_002029.4(FPR1):c.772C>T (p.Gln258Ter) AND Malignant tumor of prostate
- Germline classification:
- Uncertain significance (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000149096.3
Allele description [Variation Report for NM_002029.4(FPR1):c.772C>T (p.Gln258Ter)]
NM_002029.4(FPR1):c.772C>T (p.Gln258Ter)
Condition(s)
- Name:
- Malignant tumor of prostate
- Synonyms:
- Prostate cancer
- Identifiers:
- MONDO: MONDO:0008315; MedGen: C0376358; Orphanet: 1331; Human Phenotype Ontology: HP:0012125
-
uncharacterized protein Kpol_1031p20 [Vanderwaltozyma polyspora DSM 70294]
uncharacterized protein Kpol_1031p20 [Vanderwaltozyma polyspora DSM 70294]gi|156846172|ref|XP_001645974.1|Protein
-
Todiramphus leucopygius voucher KUNHM 15882 transforming growth factor beta 2 (T...
Todiramphus leucopygius voucher KUNHM 15882 transforming growth factor beta 2 (TGFB2) gene, exons 5, 6 and partial cdsgi|827359471|gb|KP291935.1|Nucleotide
-
Homo sapiens chromosome 17 from PAC RPCI-1 37N07 map 17p11.2 region D17S842-D17S...
Homo sapiens chromosome 17 from PAC RPCI-1 37N07 map 17p11.2 region D17S842-D17S953, complete sequencegi|13752099|emb|AL353997.3|Nucleotide
-
PREDICTED: Homo sapiens mitogen-activated protein kinase kinase kinase 20 (MAP3K...
PREDICTED: Homo sapiens mitogen-activated protein kinase kinase kinase 20 (MAP3K20), transcript variant X2, mRNAgi|2217328867|ref|XM_047444747.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Jun 17, 2024
SCV000088738